| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 91 | 2024 | 4693 | 5.230 |
Why?
|
| Fontan Procedure | 20 | 2018 | 793 | 2.170 |
Why?
|
| Heart Septal Defects, Atrial | 13 | 2009 | 468 | 1.590 |
Why?
|
| Pregnancy Complications, Cardiovascular | 14 | 2021 | 512 | 1.490 |
Why?
|
| Eisenmenger Complex | 10 | 2019 | 26 | 1.280 |
Why?
|
| Hypertension, Pulmonary | 19 | 2019 | 1553 | 1.200 |
Why?
|
| Pulmonary Artery | 15 | 2019 | 1926 | 1.080 |
Why?
|
| Cardiology | 15 | 2019 | 1704 | 1.060 |
Why?
|
| Foramen Ovale, Patent | 6 | 2014 | 214 | 1.030 |
Why?
|
| Tetralogy of Fallot | 16 | 2018 | 634 | 0.930 |
Why?
|
| Heart Ventricles | 14 | 2018 | 3805 | 0.900 |
Why?
|
| Tricuspid Valve Insufficiency | 4 | 2018 | 353 | 0.880 |
Why?
|
| Transposition of Great Vessels | 8 | 2015 | 588 | 0.850 |
Why?
|
| Biological Specimen Banks | 2 | 2018 | 765 | 0.800 |
Why?
|
| Cardiac Surgical Procedures | 17 | 2016 | 3584 | 0.770 |
Why?
|
| Heart Valve Diseases | 8 | 2020 | 1047 | 0.710 |
Why?
|
| Heart Septal Defects, Ventricular | 6 | 2012 | 491 | 0.710 |
Why?
|
| Aortic Coarctation | 6 | 2016 | 285 | 0.690 |
Why?
|
| Tricuspid Valve | 3 | 2018 | 406 | 0.620 |
Why?
|
| Exercise Tolerance | 11 | 2019 | 808 | 0.590 |
Why?
|
| Septal Occluder Device | 3 | 2014 | 132 | 0.590 |
Why?
|
| Angioplasty, Balloon | 5 | 2012 | 610 | 0.550 |
Why?
|
| Continuity of Patient Care | 3 | 2013 | 1050 | 0.530 |
Why?
|
| Heart Septal Defects | 3 | 2011 | 191 | 0.500 |
Why?
|
| Hemodynamics | 16 | 2019 | 4173 | 0.500 |
Why?
|
| Heart Failure | 12 | 2024 | 11729 | 0.490 |
Why?
|
| Exercise Test | 14 | 2019 | 2118 | 0.480 |
Why?
|
| Arterio-Arterial Fistula | 2 | 2014 | 20 | 0.480 |
Why?
|
| Adult | 128 | 2024 | 216927 | 0.480 |
Why?
|
| Galectin 3 | 1 | 2016 | 240 | 0.460 |
Why?
|
| Iloprost | 1 | 2013 | 26 | 0.440 |
Why?
|
| Prosthesis Implantation | 4 | 2014 | 590 | 0.420 |
Why?
|
| Bioprosthesis | 2 | 2014 | 601 | 0.420 |
Why?
|
| Aortic Valve | 4 | 2013 | 1992 | 0.410 |
Why?
|
| Antihypertensive Agents | 6 | 2019 | 2036 | 0.400 |
Why?
|
| Prostheses and Implants | 8 | 2012 | 1272 | 0.400 |
Why?
|
| Arrhythmias, Cardiac | 8 | 2020 | 2243 | 0.400 |
Why?
|
| Specimen Handling | 1 | 2016 | 700 | 0.400 |
Why?
|
| Heart Diseases | 8 | 2021 | 2790 | 0.390 |
Why?
|
| Pediatrics | 4 | 2019 | 3573 | 0.380 |
Why?
|
| Vasodilator Agents | 3 | 2013 | 973 | 0.380 |
Why?
|
| Humans | 194 | 2024 | 752411 | 0.370 |
Why?
|
| Coronary Vessel Anomalies | 5 | 2017 | 315 | 0.370 |
Why?
|
| Aortic Valve Insufficiency | 4 | 2015 | 583 | 0.370 |
Why?
|
| Embolism, Paradoxical | 3 | 2012 | 54 | 0.370 |
Why?
|
| Adolescent | 63 | 2019 | 86766 | 0.350 |
Why?
|
| Young Adult | 48 | 2024 | 57632 | 0.350 |
Why?
|
| Sulfonamides | 5 | 2019 | 1963 | 0.340 |
Why?
|
| Heart Valve Prosthesis | 4 | 2015 | 1500 | 0.330 |
Why?
|
| Equipment Design | 3 | 2014 | 3511 | 0.330 |
Why?
|
| Heart Atria | 4 | 2012 | 1340 | 0.320 |
Why?
|
| Exercise | 6 | 2017 | 5746 | 0.320 |
Why?
|
| Dental Implantation, Endosseous | 1 | 2013 | 521 | 0.320 |
Why?
|
| Vascular Resistance | 7 | 2013 | 927 | 0.320 |
Why?
|
| Pulmonary Circulation | 7 | 2016 | 742 | 0.320 |
Why?
|
| Pregnancy Outcome | 7 | 2021 | 2864 | 0.310 |
Why?
|
| Aorta | 2 | 2013 | 2034 | 0.310 |
Why?
|
| Aortic Aneurysm | 1 | 2013 | 638 | 0.310 |
Why?
|
| Echocardiography, Doppler | 5 | 2017 | 900 | 0.310 |
Why?
|
| Female | 122 | 2024 | 386085 | 0.310 |
Why?
|
| Ischemic Attack, Transient | 5 | 2014 | 902 | 0.310 |
Why?
|
| Follow-Up Studies | 35 | 2018 | 39077 | 0.310 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2010 | 217 | 0.310 |
Why?
|
| Pulmonary Embolism | 5 | 2012 | 2515 | 0.300 |
Why?
|
| Liver Cirrhosis | 5 | 2016 | 1892 | 0.300 |
Why?
|
| Male | 107 | 2024 | 354908 | 0.290 |
Why?
|
| Postoperative Complications | 15 | 2020 | 15438 | 0.280 |
Why?
|
| Echocardiography | 8 | 2017 | 4950 | 0.280 |
Why?
|
| Ventricular Dysfunction, Right | 5 | 2013 | 616 | 0.280 |
Why?
|
| Coronary Thrombosis | 1 | 2010 | 485 | 0.280 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 3806 | 0.270 |
Why?
|
| Pulmonary Valve | 3 | 2018 | 429 | 0.270 |
Why?
|
| Middle Aged | 77 | 2024 | 217039 | 0.260 |
Why?
|
| Ventricular Septal Rupture | 2 | 2013 | 17 | 0.260 |
Why?
|
| Thromboembolism | 3 | 2013 | 997 | 0.260 |
Why?
|
| Treatment Outcome | 39 | 2020 | 64250 | 0.260 |
Why?
|
| Disease Management | 7 | 2019 | 2480 | 0.260 |
Why?
|
| Long-Term Care | 2 | 2011 | 620 | 0.250 |
Why?
|
| Efficiency, Organizational | 1 | 2010 | 689 | 0.250 |
Why?
|
| Boston | 10 | 2018 | 9240 | 0.250 |
Why?
|
| Thrombolytic Therapy | 1 | 2014 | 2096 | 0.250 |
Why?
|
| Oxygen Consumption | 8 | 2018 | 1838 | 0.240 |
Why?
|
| American Heart Association | 8 | 2021 | 1070 | 0.240 |
Why?
|
| Fibrinolytic Agents | 1 | 2014 | 2167 | 0.230 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2019 | 3935 | 0.230 |
Why?
|
| Risk Factors | 35 | 2023 | 73425 | 0.230 |
Why?
|
| Pulmonary Atresia | 6 | 2012 | 160 | 0.230 |
Why?
|
| Aortic Valve Stenosis | 3 | 2013 | 2067 | 0.220 |
Why?
|
| Cardiac Imaging Techniques | 2 | 2017 | 275 | 0.220 |
Why?
|
| Patient Transfer | 1 | 2010 | 771 | 0.220 |
Why?
|
| Retrospective Studies | 39 | 2020 | 79133 | 0.210 |
Why?
|
| Epoprostenol | 2 | 2003 | 249 | 0.210 |
Why?
|
| Age Factors | 14 | 2019 | 18298 | 0.210 |
Why?
|
| Myocardial Perfusion Imaging | 2 | 2019 | 555 | 0.200 |
Why?
|
| Classification | 2 | 2020 | 127 | 0.200 |
Why?
|
| Stroke | 8 | 2014 | 9879 | 0.200 |
Why?
|
| Catheterization | 4 | 2011 | 1429 | 0.190 |
Why?
|
| Ventricular Function, Right | 2 | 2017 | 608 | 0.190 |
Why?
|
| Palliative Care | 4 | 2024 | 3573 | 0.190 |
Why?
|
| Registries | 7 | 2018 | 8367 | 0.180 |
Why?
|
| Patient Education as Topic | 4 | 2019 | 2294 | 0.180 |
Why?
|
| Evidence-Based Medicine | 4 | 2019 | 3678 | 0.180 |
Why?
|
| Death, Sudden, Cardiac | 6 | 2013 | 1561 | 0.180 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2020 | 64 | 0.180 |
Why?
|
| Risk Assessment | 17 | 2016 | 23788 | 0.180 |
Why?
|
| Prospective Studies | 20 | 2023 | 53809 | 0.180 |
Why?
|
| Coronary Angiography | 7 | 2016 | 4544 | 0.170 |
Why?
|
| Heart Transplantation | 4 | 2018 | 3061 | 0.170 |
Why?
|
| Venous Insufficiency | 2 | 2011 | 112 | 0.170 |
Why?
|
| Delivery, Obstetric | 3 | 2019 | 918 | 0.170 |
Why?
|
| Patient Care Planning | 1 | 2004 | 902 | 0.160 |
Why?
|
| Child | 29 | 2019 | 79004 | 0.160 |
Why?
|
| Platelet Aggregation Inhibitors | 4 | 2012 | 3160 | 0.160 |
Why?
|
| Cohort Studies | 20 | 2022 | 40980 | 0.160 |
Why?
|
| Coronary Vessels | 1 | 2010 | 3107 | 0.160 |
Why?
|
| Reoperation | 5 | 2020 | 4256 | 0.160 |
Why?
|
| Sinus of Valsalva | 2 | 2016 | 60 | 0.160 |
Why?
|
| Breathing Exercises | 1 | 2018 | 60 | 0.150 |
Why?
|
| Inhalation | 1 | 2018 | 143 | 0.150 |
Why?
|
| Respiratory Muscles | 1 | 2018 | 142 | 0.150 |
Why?
|
| Physicians | 2 | 2013 | 4551 | 0.150 |
Why?
|
| Prognosis | 15 | 2022 | 29337 | 0.150 |
Why?
|
| Aorta, Thoracic | 3 | 2013 | 1072 | 0.150 |
Why?
|
| Erythrocyte Indices | 1 | 2018 | 146 | 0.150 |
Why?
|
| Standard of Care | 2 | 2019 | 548 | 0.150 |
Why?
|
| Caregivers | 1 | 2009 | 2172 | 0.150 |
Why?
|
| Pulmonary Valve Stenosis | 3 | 2007 | 176 | 0.150 |
Why?
|
| Dilatation, Pathologic | 3 | 2013 | 518 | 0.150 |
Why?
|
| Child, Preschool | 20 | 2019 | 41660 | 0.140 |
Why?
|
| Cardiac Output, Low | 2 | 2012 | 192 | 0.140 |
Why?
|
| Pregnancy | 16 | 2021 | 29441 | 0.140 |
Why?
|
| Albuminuria | 2 | 2018 | 656 | 0.140 |
Why?
|
| Ventricular Remodeling | 3 | 2013 | 1244 | 0.140 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2017 | 86 | 0.140 |
Why?
|
| Prevalence | 12 | 2024 | 15508 | 0.140 |
Why?
|
| Ventricular Pressure | 1 | 2017 | 202 | 0.140 |
Why?
|
| United States | 28 | 2023 | 71438 | 0.140 |
Why?
|
| Dyspnea | 3 | 2012 | 1346 | 0.140 |
Why?
|
| Time Factors | 15 | 2019 | 39846 | 0.140 |
Why?
|
| Echocardiography, Stress | 1 | 2017 | 135 | 0.130 |
Why?
|
| Consensus | 3 | 2020 | 3034 | 0.130 |
Why?
|
| Hospitals, Pediatric | 4 | 2013 | 1830 | 0.130 |
Why?
|
| Referral and Consultation | 3 | 2014 | 3562 | 0.130 |
Why?
|
| Myocardial Infarction | 5 | 2013 | 11842 | 0.130 |
Why?
|
| Intracranial Embolism | 2 | 2010 | 192 | 0.130 |
Why?
|
| Vascular Surgical Procedures | 3 | 2013 | 1458 | 0.130 |
Why?
|
| Posture | 2 | 2017 | 952 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2014 | 10196 | 0.130 |
Why?
|
| Cross-Sectional Studies | 17 | 2019 | 25539 | 0.130 |
Why?
|
| Infant | 16 | 2020 | 35675 | 0.120 |
Why?
|
| Cystatin C | 1 | 2016 | 267 | 0.120 |
Why?
|
| Cheyne-Stokes Respiration | 1 | 2014 | 38 | 0.120 |
Why?
|
| Myocardial Ischemia | 2 | 2016 | 2155 | 0.120 |
Why?
|
| Scimitar Syndrome | 1 | 2014 | 31 | 0.120 |
Why?
|
| Cyanosis | 1 | 2015 | 85 | 0.120 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2015 | 50 | 0.120 |
Why?
|
| Medicine | 1 | 2023 | 932 | 0.120 |
Why?
|
| Cause of Death | 4 | 2017 | 3685 | 0.120 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2017 | 273 | 0.120 |
Why?
|
| Infant, Newborn | 12 | 2020 | 25919 | 0.120 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2019 | 1067 | 0.120 |
Why?
|
| Heart Valve Prosthesis Implantation | 5 | 2013 | 1588 | 0.120 |
Why?
|
| Anastomosis, Surgical | 2 | 2015 | 977 | 0.120 |
Why?
|
| Administration, Inhalation | 5 | 2013 | 1147 | 0.120 |
Why?
|
| Cesarean Section | 3 | 2019 | 1374 | 0.120 |
Why?
|
| Pacemaker, Artificial | 3 | 2010 | 812 | 0.120 |
Why?
|
| Data Collection | 2 | 2013 | 3301 | 0.120 |
Why?
|
| Survival Analysis | 8 | 2018 | 10172 | 0.120 |
Why?
|
| Aged | 31 | 2023 | 166585 | 0.120 |
Why?
|
| Waiting Lists | 1 | 2018 | 723 | 0.110 |
Why?
|
| Tricuspid Atresia | 1 | 2013 | 36 | 0.110 |
Why?
|
| Spirometry | 2 | 2014 | 910 | 0.110 |
Why?
|
| Clinical Protocols | 1 | 2019 | 1436 | 0.110 |
Why?
|
| Cardiac Care Facilities | 1 | 2013 | 34 | 0.110 |
Why?
|
| Paraganglioma | 1 | 2015 | 140 | 0.110 |
Why?
|
| Health Policy | 3 | 2014 | 2656 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 5 | 2016 | 7400 | 0.110 |
Why?
|
| Pulmonary Wedge Pressure | 3 | 2012 | 271 | 0.110 |
Why?
|
| Vena Cava, Superior | 2 | 2011 | 197 | 0.110 |
Why?
|
| Galectins | 1 | 2016 | 281 | 0.110 |
Why?
|
| Delivery of Health Care | 5 | 2023 | 5279 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2010 | 4632 | 0.110 |
Why?
|
| Hyaluronic Acid | 1 | 2016 | 473 | 0.110 |
Why?
|
| Canada | 4 | 2013 | 2104 | 0.110 |
Why?
|
| Warfarin | 3 | 2013 | 1506 | 0.100 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2011 | 219 | 0.100 |
Why?
|
| Pheochromocytoma | 1 | 2015 | 326 | 0.100 |
Why?
|
| Electrocardiography | 6 | 2016 | 6380 | 0.100 |
Why?
|
| Double-Blind Method | 6 | 2019 | 12328 | 0.100 |
Why?
|
| Stents | 5 | 2010 | 3298 | 0.100 |
Why?
|
| Tachycardia, Ventricular | 5 | 2013 | 1292 | 0.100 |
Why?
|
| Liver | 4 | 2016 | 7426 | 0.100 |
Why?
|
| Endocarditis, Bacterial | 2 | 2013 | 445 | 0.100 |
Why?
|
| Patient Care Management | 1 | 2015 | 299 | 0.100 |
Why?
|
| Organ Transplantation | 1 | 2022 | 1133 | 0.100 |
Why?
|
| Ebstein Anomaly | 1 | 2012 | 101 | 0.100 |
Why?
|
| Linear Models | 4 | 2015 | 5859 | 0.100 |
Why?
|
| Anesthesia, Obstetrical | 2 | 2011 | 232 | 0.100 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2012 | 192 | 0.100 |
Why?
|
| Survival Rate | 7 | 2020 | 12745 | 0.100 |
Why?
|
| Maxillary Sinus | 1 | 2013 | 181 | 0.100 |
Why?
|
| Multiple Organ Failure | 1 | 2014 | 386 | 0.100 |
Why?
|
| Risk Adjustment | 1 | 2015 | 598 | 0.090 |
Why?
|
| Brain Abscess | 1 | 2011 | 119 | 0.090 |
Why?
|
| Respiration Disorders | 1 | 2014 | 369 | 0.090 |
Why?
|
| Hospital Charges | 1 | 2013 | 361 | 0.090 |
Why?
|
| Propensity Score | 1 | 2018 | 1871 | 0.090 |
Why?
|
| Vascular Fistula | 1 | 2011 | 50 | 0.090 |
Why?
|
| Radiation Dosage | 1 | 2019 | 1969 | 0.090 |
Why?
|
| Pulmonary Edema | 2 | 2006 | 405 | 0.090 |
Why?
|
| Blood Proteins | 1 | 2016 | 1155 | 0.090 |
Why?
|
| Diastole | 1 | 2013 | 788 | 0.090 |
Why?
|
| Lung Abscess | 1 | 2010 | 41 | 0.090 |
Why?
|
| Defibrillators, Implantable | 3 | 2008 | 1481 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2001 | 2483 | 0.090 |
Why?
|
| Pregnancy, High-Risk | 1 | 2010 | 118 | 0.080 |
Why?
|
| Alveolar Bone Loss | 1 | 2013 | 388 | 0.080 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2012 | 1422 | 0.080 |
Why?
|
| Hyperaldosteronism | 1 | 2012 | 243 | 0.080 |
Why?
|
| Organizational Case Studies | 1 | 2010 | 299 | 0.080 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2015 | 732 | 0.080 |
Why?
|
| Down Syndrome | 2 | 2019 | 882 | 0.080 |
Why?
|
| Aspirin | 3 | 2013 | 3341 | 0.080 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2014 | 383 | 0.080 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2013 | 1015 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2019 | 2679 | 0.080 |
Why?
|
| Hospitals, Special | 1 | 2009 | 88 | 0.080 |
Why?
|
| Parents | 2 | 2014 | 3502 | 0.080 |
Why?
|
| Angioplasty | 1 | 2011 | 361 | 0.080 |
Why?
|
| Biomedical Research | 4 | 2013 | 3379 | 0.080 |
Why?
|
| Migraine Disorders | 3 | 2013 | 1665 | 0.080 |
Why?
|
| End Stage Liver Disease | 1 | 2013 | 334 | 0.080 |
Why?
|
| Switzerland | 1 | 2009 | 316 | 0.080 |
Why?
|
| Glomerular Filtration Rate | 1 | 2016 | 2093 | 0.080 |
Why?
|
| Ontario | 1 | 2009 | 394 | 0.080 |
Why?
|
| Nitric Oxide | 5 | 2001 | 2112 | 0.080 |
Why?
|
| Pilot Projects | 5 | 2018 | 8443 | 0.080 |
Why?
|
| Anticoagulants | 4 | 2015 | 4831 | 0.080 |
Why?
|
| Severity of Illness Index | 7 | 2018 | 15680 | 0.080 |
Why?
|
| Collateral Circulation | 2 | 2007 | 280 | 0.080 |
Why?
|
| Prosthesis-Related Infections | 1 | 2013 | 485 | 0.080 |
Why?
|
| Aldosterone | 1 | 2012 | 868 | 0.070 |
Why?
|
| Documentation | 1 | 2014 | 884 | 0.070 |
Why?
|
| Parturition | 1 | 2011 | 440 | 0.070 |
Why?
|
| Reference Values | 1 | 2015 | 4898 | 0.070 |
Why?
|
| Prosthesis Design | 2 | 2013 | 2122 | 0.070 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2014 | 1202 | 0.070 |
Why?
|
| Drainage | 2 | 2010 | 1153 | 0.070 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2012 | 853 | 0.070 |
Why?
|
| Hemoglobins, Abnormal | 1 | 2007 | 115 | 0.070 |
Why?
|
| Constriction, Pathologic | 1 | 2011 | 1099 | 0.070 |
Why?
|
| Italy | 1 | 2009 | 837 | 0.070 |
Why?
|
| Patients | 1 | 2014 | 904 | 0.070 |
Why?
|
| Streptococcal Infections | 1 | 2011 | 614 | 0.070 |
Why?
|
| Sex Factors | 4 | 2016 | 10457 | 0.070 |
Why?
|
| Cross-Over Studies | 1 | 2013 | 2032 | 0.070 |
Why?
|
| Hemoglobinopathies | 1 | 2007 | 95 | 0.070 |
Why?
|
| Radiology, Interventional | 1 | 2011 | 470 | 0.070 |
Why?
|
| Aortic Diseases | 1 | 2012 | 731 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2016 | 4114 | 0.070 |
Why?
|
| Specialization | 2 | 2022 | 768 | 0.070 |
Why?
|
| Pyrimidines | 1 | 2019 | 2979 | 0.070 |
Why?
|
| Publishing | 1 | 2014 | 834 | 0.070 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2014 | 1879 | 0.070 |
Why?
|
| Terminology as Topic | 1 | 2013 | 1527 | 0.070 |
Why?
|
| Prenatal Care | 3 | 2021 | 1104 | 0.070 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2015 | 1411 | 0.070 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2024 | 4470 | 0.070 |
Why?
|
| Tachycardia | 1 | 2008 | 603 | 0.070 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2012 | 685 | 0.070 |
Why?
|
| Oximetry | 1 | 2009 | 460 | 0.070 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 2 | 2010 | 142 | 0.070 |
Why?
|
| Secondary Prevention | 3 | 2012 | 1546 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2016 | 6501 | 0.060 |
Why?
|
| Predictive Value of Tests | 7 | 2017 | 15143 | 0.060 |
Why?
|
| Societies, Medical | 2 | 2015 | 3834 | 0.060 |
Why?
|
| Chronic Disease | 3 | 2014 | 9162 | 0.060 |
Why?
|
| Aged, 80 and over | 8 | 2019 | 58299 | 0.060 |
Why?
|
| Career Choice | 1 | 2012 | 751 | 0.060 |
Why?
|
| Therapies, Investigational | 1 | 2006 | 111 | 0.060 |
Why?
|
| Advance Care Planning | 1 | 2013 | 686 | 0.060 |
Why?
|
| Health Resources | 1 | 2011 | 920 | 0.060 |
Why?
|
| Cardiovascular System | 1 | 2012 | 846 | 0.060 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2011 | 512 | 0.060 |
Why?
|
| Heparin Antagonists | 1 | 2004 | 32 | 0.060 |
Why?
|
| Liver Function Tests | 2 | 2016 | 524 | 0.060 |
Why?
|
| Survivors | 3 | 2013 | 2325 | 0.060 |
Why?
|
| Dental Implants | 1 | 2013 | 768 | 0.060 |
Why?
|
| Fetal Heart | 1 | 2006 | 283 | 0.060 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2014 | 389 | 0.060 |
Why?
|
| Health Status | 2 | 2018 | 4050 | 0.060 |
Why?
|
| Coronary Artery Disease | 2 | 2021 | 6600 | 0.060 |
Why?
|
| Netherlands | 1 | 2009 | 2197 | 0.060 |
Why?
|
| Decompression Sickness | 1 | 2004 | 15 | 0.060 |
Why?
|
| Protamines | 1 | 2004 | 109 | 0.060 |
Why?
|
| Multivariate Analysis | 6 | 2014 | 12138 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2016 | 1882 | 0.060 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 1413 | 0.060 |
Why?
|
| Patient Admission | 1 | 2011 | 1376 | 0.060 |
Why?
|
| Patient Participation | 1 | 2013 | 1431 | 0.060 |
Why?
|
| Hospitalization | 4 | 2021 | 10629 | 0.060 |
Why?
|
| Connective Tissue Diseases | 2 | 2019 | 285 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2014 | 2173 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2016 | 21851 | 0.060 |
Why?
|
| Lower Extremity | 1 | 2011 | 1183 | 0.050 |
Why?
|
| Ultrasonography | 5 | 2013 | 5919 | 0.050 |
Why?
|
| Motor Activity | 1 | 2013 | 2677 | 0.050 |
Why?
|
| Postnatal Care | 2 | 2019 | 255 | 0.050 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2012 | 1109 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2008 | 1689 | 0.050 |
Why?
|
| Balloon Occlusion | 1 | 2004 | 127 | 0.050 |
Why?
|
| Positron-Emission Tomography | 2 | 2019 | 6413 | 0.050 |
Why?
|
| Troponin | 1 | 2006 | 516 | 0.050 |
Why?
|
| Forecasting | 2 | 2014 | 2916 | 0.050 |
Why?
|
| Proportional Hazards Models | 6 | 2016 | 12455 | 0.050 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2006 | 288 | 0.050 |
Why?
|
| Observer Variation | 3 | 2020 | 2583 | 0.050 |
Why?
|
| Patient Selection | 2 | 2018 | 4239 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2010 | 1418 | 0.050 |
Why?
|
| Aneurysm, False | 1 | 2005 | 259 | 0.050 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2004 | 588 | 0.050 |
Why?
|
| Length of Stay | 3 | 2013 | 6372 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2015 | 3327 | 0.050 |
Why?
|
| Thrombectomy | 1 | 2007 | 691 | 0.050 |
Why?
|
| Heart Function Tests | 1 | 2003 | 318 | 0.050 |
Why?
|
| Europe | 3 | 2014 | 3396 | 0.050 |
Why?
|
| Cardiac Volume | 2 | 2013 | 199 | 0.050 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2010 | 1742 | 0.050 |
Why?
|
| Equipment Failure Analysis | 1 | 2004 | 846 | 0.050 |
Why?
|
| Running | 1 | 2006 | 478 | 0.050 |
Why?
|
| Cerebrovascular Disorders | 1 | 2009 | 1492 | 0.050 |
Why?
|
| Embolization, Therapeutic | 2 | 2007 | 1394 | 0.050 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2013 | 2122 | 0.050 |
Why?
|
| Blood Circulation | 2 | 2013 | 248 | 0.050 |
Why?
|
| Electrodes, Implanted | 1 | 2006 | 824 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 3427 | 0.050 |
Why?
|
| Coronary Circulation | 2 | 2016 | 1565 | 0.050 |
Why?
|
| Thoracic Surgery | 1 | 2008 | 706 | 0.050 |
Why?
|
| Patient Readmission | 1 | 2016 | 3288 | 0.050 |
Why?
|
| Atherectomy, Coronary | 1 | 2001 | 145 | 0.050 |
Why?
|
| Kidney | 1 | 2016 | 6984 | 0.050 |
Why?
|
| Combined Modality Therapy | 3 | 2012 | 8539 | 0.050 |
Why?
|
| Regional Medical Programs | 1 | 2001 | 68 | 0.050 |
Why?
|
| Abortion, Spontaneous | 1 | 2006 | 526 | 0.050 |
Why?
|
| Terminal Care | 1 | 2013 | 1728 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 3821 | 0.040 |
Why?
|
| Infusions, Intravenous | 2 | 2003 | 2221 | 0.040 |
Why?
|
| Congresses as Topic | 2 | 2016 | 795 | 0.040 |
Why?
|
| Extraction, Obstetrical | 1 | 2019 | 27 | 0.040 |
Why?
|
| Incidence | 7 | 2013 | 21157 | 0.040 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 3203 | 0.040 |
Why?
|
| Health Services Accessibility | 2 | 2014 | 5282 | 0.040 |
Why?
|
| Valsalva Maneuver | 1 | 2019 | 98 | 0.040 |
Why?
|
| Creatinine | 2 | 2016 | 1892 | 0.040 |
Why?
|
| Drug Administration Schedule | 2 | 2007 | 4876 | 0.040 |
Why?
|
| Gadolinium DTPA | 1 | 2002 | 825 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2014 | 4343 | 0.040 |
Why?
|
| Inspiratory Capacity | 1 | 2018 | 35 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2004 | 1730 | 0.040 |
Why?
|
| Acetylcholine | 3 | 1996 | 629 | 0.040 |
Why?
|
| ROC Curve | 2 | 2017 | 3532 | 0.040 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2001 | 487 | 0.040 |
Why?
|
| Disease Progression | 3 | 2013 | 13405 | 0.040 |
Why?
|
| Recovery of Function | 2 | 2019 | 2921 | 0.040 |
Why?
|
| Diuretics | 1 | 2001 | 611 | 0.040 |
Why?
|
| Gestational Age | 1 | 2006 | 3545 | 0.040 |
Why?
|
| Hexosaminidases | 1 | 2016 | 45 | 0.040 |
Why?
|
| Reproducibility of Results | 4 | 2017 | 19901 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2010 | 3209 | 0.030 |
Why?
|
| Databases, Factual | 2 | 2012 | 7897 | 0.030 |
Why?
|
| Pulmonary Ventilation | 1 | 2018 | 371 | 0.030 |
Why?
|
| Endocardial Cushion Defects | 1 | 1996 | 43 | 0.030 |
Why?
|
| Sarcoidosis | 1 | 2001 | 515 | 0.030 |
Why?
|
| Cardiovascular Diseases | 2 | 2012 | 15622 | 0.030 |
Why?
|
| Postpartum Hemorrhage | 1 | 2019 | 261 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 12901 | 0.030 |
Why?
|
| Heart-Lung Transplantation | 1 | 1995 | 86 | 0.030 |
Why?
|
| Self Report | 2 | 2018 | 3647 | 0.030 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2016 | 320 | 0.030 |
Why?
|
| Patient Positioning | 1 | 2017 | 325 | 0.030 |
Why?
|
| Urinalysis | 1 | 2016 | 367 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2024 | 1912 | 0.030 |
Why?
|
| Comorbidity | 3 | 2013 | 10475 | 0.030 |
Why?
|
| Electric Countershock | 2 | 2008 | 536 | 0.030 |
Why?
|
| Social Support | 1 | 2024 | 2118 | 0.030 |
Why?
|
| Cardiac Output | 1 | 2016 | 832 | 0.030 |
Why?
|
| Thrombosis | 1 | 2007 | 3018 | 0.030 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2015 | 153 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2004 | 3468 | 0.030 |
Why?
|
| Brachytherapy | 1 | 2001 | 1241 | 0.030 |
Why?
|
| Biopsy | 2 | 2016 | 6743 | 0.030 |
Why?
|
| Smoking | 1 | 2010 | 9028 | 0.030 |
Why?
|
| Blood Pressure | 3 | 2017 | 8465 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2023 | 5148 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 1614 | 0.030 |
Why?
|
| Anemia, Hemolytic | 1 | 2013 | 163 | 0.030 |
Why?
|
| Streptococcus intermedius | 1 | 2011 | 3 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2015 | 4002 | 0.030 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2003 | 1342 | 0.030 |
Why?
|
| Life Tables | 2 | 2004 | 366 | 0.030 |
Why?
|
| Trace Elements | 1 | 2014 | 196 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2015 | 14588 | 0.020 |
Why?
|
| Lung Diseases, Obstructive | 1 | 1993 | 308 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2014 | 35932 | 0.020 |
Why?
|
| Myocardial Revascularization | 1 | 2016 | 842 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2003 | 2688 | 0.020 |
Why?
|
| Postoperative Period | 2 | 2012 | 1806 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 1632 | 0.020 |
Why?
|
| Disease-Free Survival | 2 | 2016 | 6780 | 0.020 |
Why?
|
| Coronary Sinus | 1 | 2011 | 84 | 0.020 |
Why?
|
| Sternotomy | 1 | 2012 | 124 | 0.020 |
Why?
|
| Bilirubin | 1 | 2013 | 436 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2018 | 1341 | 0.020 |
Why?
|
| Trial of Labor | 1 | 2011 | 80 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2012 | 474 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 10796 | 0.020 |
Why?
|
| Delayed Diagnosis | 1 | 2014 | 452 | 0.020 |
Why?
|